Role of neural modulation in the pathophysiology of atrial fibrillation

Indian Journal of Medical Research

Volumn 139, Issue APR, 2014, Pages 512-522

  Male, Shailesh ^a   Scherlag, Benjamin J ^a  

^a Heart Rhythm Institute   (United States)

Author keywords

Atrial fibrillation; Ganglionated plexus plexi; Neuro modulation; Vagus nerve stimulation

Indexed keywords

ACETYLCHOLINE; ANTIARRHYTHMIC AGENT; MAGNETIC NANOPARTICLE; NEUROTOXIN; NEUROTRANSMITTER; PEPTIDE; UNCLASSIFIED DRUG; VASOSTATIN 1;

AUTONOMIC NERVOUS SYSTEM; BOLD SIGNAL; CALCIUM TRANSPORT; CATHETER ABLATION; ECTOPIA CORDIS; ELECTROGRAPHY; EVOKED RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GANGLIONATED PLEXI; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE REFRACTORY PERIOD; HUMAN; MULTIPLE SCLEROSIS; MULTIPLE WAVELET HYPOTHESIS; NERVE CELL NETWORK; NEUROMODULATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PULMONARY VEIN ISOLATION; REVIEW; VAGUS NERVE STIMULATION; ATRIAL FIBRILLATION; AUTONOMIC GANGLION; BIOLOGICAL MODEL; FEMALE; MALE; PREVALENCE; PULMONARY VEIN; UNITED STATES;

ATRIAL FIBRILLATION; FEMALE; GANGLIA, AUTONOMIC; HUMANS; MALE; MODELS, BIOLOGICAL; NERVE NET; PREVALENCE; PULMONARY VEINS; UNITED STATES;

EID: 84902162977     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104: 1534-9.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-25.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
4. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 study. Circulation 2014; 129: 837-47.
5. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl 3): 429S-56S.
6. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-33.
7. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101-98.
8. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66.
9. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-6.
10. Shah DC, Haissaguerre M, Jais P. Catheter ablation of pulmonary vein foci for atrial fibrillation: PV foci ablation for atrial fibrillation. Thorac Cardiovasc Surg 1999; 47 (Suppl 3): 352-6.
11. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-81.
12. Pappone C, Santinelli V. Pulmonary vein isolation by circumferential radiofrequency lesions in atrial fibrillation. From substrate to clinical outcome. Ann Ist Super Sanita 2001; 37: 401-7.
13. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539-44.
14. Verma A, Marrouche NF, Natale A. Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol 2004; 15: 1335-40.
15. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm electrophysiol 2010; 3: 32-8.
16. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-6.
17. Sorgente A, Tung P, Wylie J, Josephson ME. Six year follow-up after catheter ablation of atrial fibrillation: a palliation more than a true cure. Am J Cardiol 2012; 109: 1179-86.
18. Bertaglia E, Tondo C, De Simone A, Zoppo F, Mantica M, Turco P, et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace 2010; 12: 181-7.
19. Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, et al. Catheter ablation of longstanding-persistent atrial fibrillation: Five-year multiple procedure outcomes of the hamburg sequential ablation strategy. Heart Rhythm 2012; 9: S198-9.
20. Chao TF, Tsao HM, Lin YJ, Tsai CF, Lin WS, Chang SL, et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. CircArrhythm Electrophysiol 2012; 5: 514-20.
21. O'Neill MD, Wright M, Knecht S, Jais P, Hocini M, Takahashi Y, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J 2009; 30: 1105-12.
22. Burkhardt JD, Di Biase L, Natale A. Long-standing persistent atrial fibrillation: the metastatic cancer of electrophysiology. J Am Coll Cardiol 2012; 60: 1930-2.
23. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2044-53.
24. Lockwood E, Nademanee K. Electrogram-guided ablation. In: Calkins H, Jais P, Steinberg J, editors. A practical approach to catheter ablation of atrial fibrillation. Philadelphia: Lipincott, Williams & Wilkins; 2008. p. 214-30.
25. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S, et al. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Inter Card Electrophysiol 2005; 13 (Suppl 1): 37-42.
26. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm 2011; 8: 672-8.
27. Gibson DN, Di Biase L, Mohanty P, Patel JD, Bai R, Sanchez J, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm 2011; 8: 1364-71.
28. Schwarz N, Kuniss M, Nedelmann M, Kaps M, Bachmann G, Neumann T, et al. Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm 2010; 7: 1761-7.
29. Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E, Cesarani F, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation 2010; 122: 1667-73.
30. Scherf D. Studies on auricular tachycardia caused by aconitine administration. Proc Soc Exp Biol Med 1947; 64: 233-9.
31. Scherf D, Morgenbesser LJ, Nightingale EJ, Schaeffeler KT. Further studies on mechanism of auricular fibrillation. Proc Soc Exp Biol Med 1950; 73: 650-8.
32. Moe GK. On multiple wavelet hypothesis of atrial fibrillation. Arch IntPharmacodyn Ther 1962; 140: 183-8.
33. Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Ame Heart J 1964; 67: 200-20.
34. Wil AL, Cranefield PF. Reentrant excitation as a cause of cardiac arrhythmias. Am J Physiol 1978; 235: H1-17.
35. Nattel S. Atrial electrophysiology and mechanisms of atrial fibrillation. J Cardiovasc Pharmacol Ther 2003; 8 (Suppl 1): S5-11.
36. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70.
37. Allessie MA, Lammers WJEP, Bonke FJM, Hollen J. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology and arrhythmias. Orlando: Grune and Stratton; 1985. p. 265-75.
38. Cox JL, Boineau JP, Schuessler RB, Ferguson TB, Jr, Cain ME, Lindsay BD, et al. Successful surgical treatment of atrial fibrillation. Review and clinical update. JAMA 1991; 266: 1976-80.
39. Lu TM, Tai CT, Hsieh MH, Tsai CF, Lin YK, Yu WC, et al. Electrophysiologic characteristics in initiation of paroxysmal atrial fibrillation from a focal area. J Am Coll Cardiol 2001; 37: 1658-64.
40. Chang KC, Lin YC, Chen JY, Chou HT, Hung JS. Electrophysiological characteristics and radiofrequency ablation of focal atrial tachycardia originating from the superior vena cava. Jpn Circ J2001; 65: 1034-40.
41. Lee SH, Tai CT, Lin WS, Tsai CF, Hsieh MH, Yu WC, et al. Predicting the arrhythmogenic foci of atrial fibrillation before atrial transseptal procedure: Implication for catheter ablation. J Cardiovasc Electr Ophysiol 2000; 11: 750-7.
42. Tsai CF, Tai CT, Hsieh MH, Lin WS, Yu WC, Ueng KC, et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation 2000; 102: 67-74.
43. Hsu LF, Jais P, Keane D, Wharton JM, Deisenhofer I, Hocini M, et al. Atrial fibrillation originating from persistent left superior vena cava. Circulation 2004; 109: 828-32.
44. Mansour M, Ruskin J, Keane D. Initiation of atrial fibrillation by ectopic beats originating from the ostium of the inferior vena cava. J Cardiovasc Electrophysiol 2002; 13: 1292-5.
45. Hwang C, Wu TJ, Doshi RN, Peter CT, Chen PS. Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation. Circulation 2000; 101: 1503-5.
46. Polymeropoulos KP, Rodriguez LM, Timmermans C, Wellens HJ. Images in cardiovascular medicine. Radiofrequency ablation of a focal atrial tachycardia originating from the Marshall ligament as a trigger for atrial fibrillation. Circulation 2002; 105: 2112-3.
47. Natale A, Pisano E, Beheiry S, Richey M, Leonelli F, Fanelli R, et al. Ablation of right and left atrial premature beats following cardioversion in patients with chronic atrial fibrillation refractory to antiarrhythmic drugs. Am J Cardiol 2000; 85: 1372-5.
48. Scherlag BJ, Yamanashi W, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol 2005; 45: 1878-86.
49. Lazzara R, Scherlag BJ, Robinson MJ, Samet P. Selective in situ parasympathetic control of the canine sinoatrial and atrioventricular nodes. Circ Res 1973; 32: 393-01.
50. Burkholder T, Chambers M, Hotmire K, Wurster RD, Moody S, Randall WC. Gross and microscopic anatomy of vagal innervation of the rat heart. AmatRec 1992; 232: 444-52.
51. Po SS, Scherlag BJ, Yamanashi WS, Edwards J, Zhou J, Wu R, et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm 2006; 3: 201-8.
52. Lemola K, Chartier D, Yeh YH, Dubuc M, Cartier R, Armour A, et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation 2008; 117: 470-7.
53. Scherlag BJ, Patterson E, Po SS. The neural basis of atrial fibrillation. JElectrocardiol2006; 39 (Suppl 4): S180-3.
54. Patterson E, Po SS, Scherlag BJ, Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005; 2: 624-31.
55. Patterson E, Lazzara R, Szabo B, Liu H, Tang D, Li YH, et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol 2006; 47: 1196-206.
56. Park HW, Shen MJ, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol 2012; 27: 24-8.
57. Ardell JL. Structure and function of the mammalian intrinsic cardiac neurons. In: Armour JA, Ardell JL, editors. Neurocardiology. New York: Oxford University Press; 1994. p. 95-114.
58. Ardell JL. Intrathoracic neuronal regulation of cardiac function. In: Armour JA, Ardell JL, editors. Basic and clinical neurocardiology. New York: Oxford University Press; 2004. p. 118-52.
59. Zhang Y, Scherlag BJ, Lu Z, Niu GD, Yamanashi WS, Hogan C, et al. Comparison of atrial fibrillation inducibility by electrical stimulation of either the extrinsic or the intrinsic autonomic nervous systems. J Interv Card Electrophysiol 2009; 24: 5-10.
60. Scherlag BJ, Nakagawa H, Jackman WM, Lazzara R, Po SS. Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications. J Cardiovasc Transl Res 2011; 4: 35-41.
61. Smith FM, McGuirt AS, Leger J, Armour JA, Ardell JL. Effects of chronic cardiac decentralization on functional properties of canine intracardiac neurons in vitro. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1474-82.
62. Smith FM, McGuirt AS, Hoover DB, Armour JA, Ardell JL. Chronic decentralization of the heart differentially remodels canine intrinsic cardiac neuron muscarinic receptors. Am J Physiol Heart Circ Physiol 2001; 281: H1919-30.
63. Schauerte P, Scherlag BJ, Patterson E, Scherlag MA, Matsudaria K, Nakagawa H, et al. Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol 2001; 12: 592-9.
64. Hou Y, Scherlag BJ, Lin J, Zhang Y, Lu Z, Truong K, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007; 50: 61-8.
65. Lin J, Scherlag BJ, Niu G, Lu Z, Patterson E, Liu S, et al. Autonomic elements within the ligament of Marshall and inferior left ganglionated plexus mediate functions of the atrial neural network. J Cardiovasc Electrophysiol 2009; 20: 318-24.
66. Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L, et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol 2008; 1: 184-92.
67. Lin J, Scherlag BJ, Lu Z, Zhang Y, Liu S, Patterson E, et al. Inducibility of atrial and ventricular arrhythmias along the ligament of marshall: role of autonomic factors. J Cardiovasc Electrophysiol 2008; 19: 955-62.
68. Platt M, Mandapati R, Scherlag BJ, Yamanashi W, Nakagawa H, Lazzara R, et al. Limiting the number and extent of radiofrequency applications to terminate atrial fibrillation and subsequently prevent its inducibility. Heart Rhythm 2004; 1 (Suppl 1): S11.
69. Scanavacca M, Pisani CF, Hachul D, Lara S, Hardy C, Darrieux F, et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation 2006; 114: 876-85.
70. Katritsis D, Giazitzoglou E, Sougiannis D, Goumas N, Paxinos G, Camm AJ. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol 2008; 102: 330-4.
71. Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm 2009; 6: 1257-64.
72. Scanavacca M, Sosa E. Catheter ablation techniques for selective cardiac autonomic denervation to treat patients with paroxysmal atrial fibrillation. Heart Rhythm 2009; 6: 1265-6.
73. Hirose M, Leatmanoratn Z, Laurita KR, Carlson MD. Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation. J Cardiovasc Electrophysiol 2002; 13:
74. Oh S, Zhang Y, Bibevski S, Marrouche NF, Natale A, Mazgalev TN. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm 2006; 3: 701-8.
75. Li S, Scherlag BJ, Yu L, Sheng X, Zhang Y, Ali R, et al. Low- level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation. Circ Arrhythm electrophysiol 2009; 2: 645-51.
76. Sheng X, Scherlag BJ, Yu L, Li S, Ali R, Zhang Y, et al. Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. J Am Coll Cardiol 2011; 57: 563-71.
77. Yu L, Scherlag BJ, Li S, Sheng X, Lu Z, Nakagawa H, et al. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac Ganglia. J Cardiovasc Electrophysiol 2011; 22: 455-63.
78. Sha Y, Scherlag BJ, Yu L, Sheng X, Jackman WM, Lazzara R, et al. Low-level right vagal stimulation: anticholinergic and antiadrenergic effects. J Cardiovasc Electrophysiol 2011; 22: 1147-53.
79. Shen MJ, Shinohara T, Park HW, Frick K, Ice DS, Choi EK, et al. Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines. Circulation 2011; 123: 2204-12.
80. Gallo MP, Levi R, Ramella R, Brero A, Boero O, Tota B, et al. Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium. Am J Physiol Heart Circ Physiol 2007; 292: H2906-12.
81. Schachter SC, Saper CB. Vagus nerve stimulation. Epilepsia 1998; 39: 677-86.
82. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002; 1: 477-82.
83. Grimm S, Bajbouj M. Efficacy of vagus nerve stimulation in the treatment of depression. Expert Rev Neurother 2010; 10: 87-92.
84. Fahy BG. Intraoperative and perioperative complications with a vagus nerve stimulation device. J Clin Anesth 2010; 22: 213-22.
85. Yu L, Scherlag BJ, Li S, Fan Y, Dyer J, Male S, et al. Low- level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: A non-invasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm 2013; 10: 428-35.
86. Dietrich S, Smith J, Scherzinger C, Hofmann-Preiss K, Freitag T, Eisenkolb A, et al. A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI. Biomed Tech (Berl) 2008; 53: 104-11.
87. Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, et al. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm 2003; 110: 1437-43.
88. Polak T, Markulin F, Ehlis AC, Langer JB, Ringel TM, Fallgatter AJ. Far field potentials from brain stem after transcutaneous vagus nerve stimulation: optimization of stimulation and recording parameters. J Neural Transm 2009; 116: 1237-42.
89. Yu L, Scherlag BJ, Dormer K, Nguyen KT, Pope C, Fung KM, et al. Autonomic denervation with magnetic nanoparticles. Circulation 2010; 122: 2653-9.
90. Jacobson JI, Yamanashi WS. An initial physical mechanism in the treatment of neurologic disorders with externally applied pico Tesla magnetic fields. Neurol Res 1995; 17: 144-8.
91. Sandyk R, Derpapas. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. Int J Neurosci 1993; 70: 97-105.
92. Tokimura H, Nomaguchi S, Hirahara K, Kadota K, Asakura T. Transcranial magnetic stimulation of the facial nerves. Rinsho Shinkeigaku 1992; 32: 385-7.
93. Seki Y, Krain L, Yamada T, Kimura J. Transcranial magnetic stimulation of the facial nerve: recording technique and estimation of the stimulated site. Neurosurgery 1990; 26: 286-90.
94. Maccabee PJ, Amassian VE, Cracco RQ, Cracco JB, Anziska BJ. Intracranial stimulation of facial nerve in humans with the magnetic coil. Electroencephalogr Clin Neurophysiol 1988; 70: 350-4.
95. Zipes DP. Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system. Cleve Clin J Med 2008; 75 (Suppl 2): S94-6.
96. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 2008; 10: 884-91.
97. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-4.
98. Mravec B, Hulin I. Does vagus nerve constitute a self-organization complexity or a hidden network? Bratisl Lek Listy 2006; 107: 3-8.